124 related articles for article (PubMed ID: 12116035)
1. Prophylaxis and treatment of influenza encephalitis in an experimental mouse model.
Shinjoh M; Yoshikawa T; Li Y; Shiraishi K; Ueki H; Nerome K
J Med Virol; 2002 Jul; 67(3):406-17. PubMed ID: 12116035
[TBL] [Abstract][Full Text] [Related]
2. Neurovirulence of H7N7 influenza A virus: brain stem encephalitis accompanied with aspiration pneumonia in mice.
Shinya K; Suto A; Kawakami M; Sakamoto H; Umemura T; Kawaoka Y; Kasai N; Ito T
Arch Virol; 2005 Aug; 150(8):1653-60. PubMed ID: 15841337
[TBL] [Abstract][Full Text] [Related]
3. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
4. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
[TBL] [Abstract][Full Text] [Related]
5. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
[TBL] [Abstract][Full Text] [Related]
6. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
[TBL] [Abstract][Full Text] [Related]
7. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
[TBL] [Abstract][Full Text] [Related]
8. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
Brett IC; Johansson BE
Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous immunization with inactivated influenza virus induces protective immune responses.
Skountzou I; Quan FS; Jacob J; Compans RW; Kang SM
Vaccine; 2006 Aug; 24(35-36):6110-9. PubMed ID: 16766095
[TBL] [Abstract][Full Text] [Related]
10. Successful protection by amantadine hydrochloride against lethal encephalitis caused by a highly neurovirulent recombinant influenza A virus in mice.
Mori I; Liu B; Hossain MJ; Takakuwa H; Daikoku T; Nishiyama Y; Naiki H; Matsumoto K; Yokochi T; Kimura Y
Virology; 2002 Nov; 303(2):287-96. PubMed ID: 12490390
[TBL] [Abstract][Full Text] [Related]
11. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
12. Avian influenza vaccines and therapies for poultry.
Swayne DE
Comp Immunol Microbiol Infect Dis; 2009 Jul; 32(4):351-63. PubMed ID: 18442853
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of mini-plasmin in the cerebral capillaries causes vascular invasion of the murine brain by a pneumotropic influenza A virus: implications for influenza-associated encephalopathy.
Yao D; Chen Y; Kuwajima M; Shiota M; Kido H
Biol Chem; 2004 Jun; 385(6):487-92. PubMed ID: 15255180
[TBL] [Abstract][Full Text] [Related]
14. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.
Ninomiya A; Imai M; Tashiro M; Odagiri T
Vaccine; 2007 May; 25(18):3554-60. PubMed ID: 17293015
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of influenza].
Bricaire F
Rev Prat; 1979 May; 29(27):2237-47. PubMed ID: 94691
[No Abstract] [Full Text] [Related]
16. Intranasal delivery of whole influenza vaccine prevents subsequent allergen-induced sensitization and airway hyper-reactivity in mice.
Minne A; Jaworska J; Gerhold K; Ahrens B; Avagyan A; Vanbever R; Matricardi PM; Schmidt AC; Hamelmann E
Clin Exp Allergy; 2007 Aug; 37(8):1250-8. PubMed ID: 17651156
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
[TBL] [Abstract][Full Text] [Related]
18. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
[TBL] [Abstract][Full Text] [Related]
19. Emergence and transmission of amantadine-resistant influenza A in a nursing home.
Schilling M; Gravenstein S; Drinka P; Cox N; Krause P; Povinelli L; Shult P
J Am Geriatr Soc; 2004 Dec; 52(12):2069-73. PubMed ID: 15571544
[TBL] [Abstract][Full Text] [Related]
20. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
